Estrogens are powerful modulators of neuronal physiology and in humans may affect a broad range of functions, including reproductive, emotional, and cognitive behaviors. We studied the contribution of estrogen receptors (ERs) in modulation of emotional processes and analyzed the effects of deleting ER␣ or ER in mice. Behavior consistent with increased anxiety was observed principally in ER mutant females and was associated with a reduced threshold for the induction of synaptic plasticity in the basolateral amygdala. Local increase of 5-hydroxytryptamine 1a receptor expression in medial amygdala may contribute to these changes. Our data show that, particularly in females, there is an important role for ER-mediated estrogen signaling in the processing of emotional behavior.
There is a strong link between estrogen and emotional disturbances in humans. Mood fluctuations, depression, irritability, and anxiety have often been associated with low levels of estradiol in postmenopausal women (1, 2), whereas estrogen replacement therapy ameliorates these psychological conditions (1-3). Reduced estrogen signaling in rodents leads to behavior indicative of increased anxiety (4, §). Little is known, however, about either the mechanisms or sites of estrogen actions in these modulatory processes, or the neurotransmitter systems involved in these regulations.In the nervous system, estrogen signals are transduced by both nuclear estrogen receptors (ER␣ and ER), which act as transcription factors, and by a nongenomic pathway, which has yet to be identified. Both receptors show similar patterns of expression and are found at abundance in medial amygdala, bed nucleus of stria terminalis and preoptic area, whereas in hippocampus, ER␣ is the predominant ER isotype in mouse (5). Recent analysis of reproductive and aggressive behavior in ER␣ and ER null mutant mice provided the first clear evidence for a role for ERs in brain functions (6-8).High levels of estrogens have been shown to increase dendrite growth and synaptic plasticity in the rat hippocampus in vitro and in vivo (9, 10). Furthermore, the in vivo experiments revealed that estrogen enhances neuronal excitability in the hippocampus (11). In the basolateral amygdala, a structure involved in fear and anxiety, estrogens have quite the opposite effect and reduce neuronal excitability (11,12). Although the exact mode of action by which estrogen exerts its diverse effects is not clear, it is almost certain that the inhibitory neurotransmitter ␥-aminobutyric acid (GABA) is involved (13, 14, ¶). GABA is implicated in fear and anxiety, on the evidence of both pharmacological (15, 16) and gene-targeting (17, 18) experiments. Regulation of the expression of the GABA synthesizing enzyme glutamic acid decarboxylase (GAD) by ERs (13, ¶, 19) may be crucial to modulation of GABA type A activity and, therefore, to fear and anxiety. Moreover, GABAergic tone in amygdala can be affected by serotonergic signaling (20, 21), which in turn can be downregulated by estrogen's effects on the 5-h...